A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland

Vox Sanguinis

Volumn 76, Issue 3, 1999, Pages 175-180

  Smith, Donald B ^a   Lawlor, Emer ^b,c   Power, Joan ^b,c   O'Riordan, Joan ^b,c   McAllister, Jane ^a   Lycett, Carol ^d   Davidson, Fiona ^d   Pathirana, Steve ^a   Garson, Jeremy A ^e   Tedder, Richard S ^e   Yap, Peng Lee ^d   Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Irish Blood Transfusion Services   (Ireland)

^c St Finbarr's Hospital   (Ireland)

^d Edinburgh S E Scotland Blood T   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RHESUS D ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD DONOR; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRAVENOUS DRUG ADMINISTRATION; IRELAND; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SERODIAGNOSIS; SEROPREVALENCE; VIRUS GENE;

EID: 0032910273     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031045     Document Type: Article

References (19)

1. Dittmann S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt F: Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991;13:323-327.
2. Hohne M, Schreier E, Roggendorf M: Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Arch Virol 1994;137:25-34.
3. Power JP, Lawlor E, Davidson F, Yap PL, Kenny-Walsh E, Whelton MJ, Walsh TJ: Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin. Lancet 1994;344: 1166-1167.
4. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P: Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995;345:1211-1213.
5. Expert Group: Report of the Expert Group on the Blood Transfusion Board. Pn 1538, Stationery Office, Dublin, 1995.
6. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P: The origin of hepatitis C virus genotypes. J Gen Virol 1997; 78:321-328.
7. McAllister J, Casino C, Davidson F, Power J, Lawlor E, Yap PL, Simmonds P, Smith DB: Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 1998;72:4893-4905.
8. Hoppe HH, Mester T, Hennig W, Krebs HJ: Prevention of Rh-immunization: Modified production of IgG anti-Rh for intravenous application by ion exchange chromatography (IEC). Vox Sang 1973;25:308-316.
9. Chan S-W, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992;73:1131-1141.
10. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, Seed CRG, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Olim G, Duraisamy G, Cuypers T, Saeed AA, Teo D, Conradie J, Kew MC, Lin M, Nuchaprayoon, C, Ndimbie OK, Yap PL: Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995;76:1197-1204.
11. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P1 International Collaborators: Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: Implications for virus classification. J Gen Virol 1995;76:2493-2507.
12. Whitby K, Garson JA: Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA. J Virol Methods 1995;51:75-88.
13. Saldanha J, Minor P: Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR. Vox Sang 1996;70:148-151.
14. Kumar S, Tamura K, Nei M: MEGA: Molecular Evolutionary Genetics Analysis, version 1.0. University Park, Pennsylvania State University, 1993.
15. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian KP, Kohara M, Simmonds P, Urdea MS: Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995;171:281-289.
16. Lawlor E, Power J, Garson JA, Yap P-L, Davidson F, Columb G, Smith DB, Pomeroy L, O'Riordan J, Simmonds P, Tedder RS: Transmission rates of HCV by different batches of a contaminated anti-D immunoglobulin preparation. Vox Sang 1999;76:138-143.
17. Crawford RJ, Gillon J, Yap PL, Brookes E, McOmish F, Simmonds P, Dow BC, Follett EAC: Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med 1994;4:121-124.
18. Shakil AO, Conrycantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, Krawczynski K, Conjeevaram HS, Sallie R, Dibisceglie AM, Melpolder JC, Hoofnagle JH: Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995;123: 330-337.
19. Macdonald M, Crofts N, Kaldor J: Transmission of hepatitis C virus: Rates, routes, and cofactors. Epidemiol Rev 1996;18:137-148.